Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.20.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of segment reporting information

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2020     2019     2020     2019  
Revenues                        
Real property operations   $ 301,267     $ 264,889     $ 598,223     $ 531,515  
Medical related consulting services - related parties     -       111,434       -       125,694  
Development services and sales of developed products     -       23,404       -       26,682  
Total     301,267       399,727       598,223       683,891  
Costs and expenses                                
Real property operations     272,764       192,676       527,265       423,435  
Medical related consulting services - related parties     -       95,375       -       108,466  
Development services and sales of developed products     -       31,784       -       62,091  
Total     272,764       319,835       527,265       593,992  
Gross profit (loss)                                
Real property operations     28,503       72,213       70,958       108,080  
Medical related consulting services - related parties     -       16,059       -       17,228  
Development services and sales of developed products     -       (8,380 )     -       (35,409 )
Total     28,503       79,892       70,958       89,899  
Other operating expenses                                
Real property operations     103,218       67,691       214,034       177,597  
Medical related consulting services - related parties     175,891       60,943       331,126       240,071  
Development services and sales of developed products     30,240       222,077       66,239       442,958  
Corporate/Other     2,721,981       4,072,933       5,684,578       8,038,338  
Total     3,031,330       4,423,644       6,295,977       8,898,964  
Other income (expense)                                
Interest expense                                
Real property operations     -       (8,219 )     -       (32,877 )
Corporate/Other     (42,469 )     (13,242 )     (84,638 )     (16,225 )
Total     (42,469 )     (21,461 )     (84,638 )     (49,102 )
Other income (expense)                                
Real property operations     4       7       (931 )     15  
Medical related consulting services - related parties     (11,091 )     (9,743 )     (16,578 )     (21,854 )
Development services and sales of developed products     1       51       3       179  
Corporate/Other     -       (63,925 )     -       (63,925 )
Total     (11,086 )     (73,610 )     (17,506 )     (85,585 )
Total other income (expense)     (53,555 )     (95,071 )     (102,144 )     (134,687 )
Net loss                                
Real property operations     74,711       3,690       144,007       102,379  
Medical related consulting services - related parties     186,982       54,627       347,704       244,697  
Development services and sales of developed products     30,239       230,406       66,236       478,188  
Corporate/Other     2,764,450       4,150,100       5,769,216       8,118,488  
Total   $ 3,056,382     $ 4,438,823     $ 6,327,163     $ 8,943,752  

 

Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019   June 30,
2020
    December 31,
2019
 
Real property operating   $ 7,668,501     $ 7,750,743  
Medical related consulting services     232,914       263,621  
Development services and sales of developed products     273,559       322,741  
Total   $ 8,174,974     $ 8,337,105  

 

Identifiable long-lived tangible assets at June 30, 2020 and December 31, 2019   June 30,
2020
    December 31,
2019
 
United States   $ 7,746,413     $ 7,839,093  
China     428,561       498,012  
Total   $ 8,174,974     $ 8,337,105